Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

Jonathan Ledermann; Philipp Harter; Charlie Gourley; Michael Friedlander; Ignace Vergote; Gordon Rustin; Clare L. Scott; Werner Meier; Ronnie Shapira-Frommer; Tamar Safra; Daniela Matei; Anitra Fielding; Stuart Spencer; Brian Dougherty; Maria Orr; Darren Hodgson; J. Carl Barrett; Ursula Matulonis

doi:10.1097/ogx.0000000000000107

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare L. Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra, Daniela Matei, Anitra Fielding, Stuart Spencer, Brian Dougherty, Maria Orr, Darren Hodgson, J. Carl Barrett, Ursula Matulonis

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	594-596
Number of pages	3
Journal	Obstetrical and Gynecological Survey
Volume	69
Issue number	10
DOIs	https://doi.org/10.1097/ogx.0000000000000107
State	Published - 2015

ASJC Scopus subject areas

Obstetrics and Gynecology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/ogx.0000000000000107

Cite this

Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C. L., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Fielding, A., Spencer, S., Dougherty, B., Orr, M., Hodgson, D., Barrett, J. C., & Matulonis, U. (2015). Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Obstetrical and Gynecological Survey, 69(10), 594-596. https://doi.org/10.1097/ogx.0000000000000107

@article{78fbd9171bbc4e739dfad59fe1194a85,

title = "Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial",

author = "Jonathan Ledermann and Philipp Harter and Charlie Gourley and Michael Friedlander and Ignace Vergote and Gordon Rustin and Scott, {Clare L.} and Werner Meier and Ronnie Shapira-Frommer and Tamar Safra and Daniela Matei and Anitra Fielding and Stuart Spencer and Brian Dougherty and Maria Orr and Darren Hodgson and Barrett, {J. Carl} and Ursula Matulonis",

year = "2015",

doi = "10.1097/ogx.0000000000000107",

language = "English (US)",

volume = "69",

pages = "594--596",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "10",

}

Ledermann, J, Harter, P, Gourley, C, Friedlander, M, Vergote, I, Rustin, G, Scott, CL, Meier, W, Shapira-Frommer, R, Safra, T, Matei, D, Fielding, A, Spencer, S, Dougherty, B, Orr, M, Hodgson, D, Barrett, JC & Matulonis, U 2015, 'Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial', Obstetrical and Gynecological Survey, vol. 69, no. 10, pp. 594-596. https://doi.org/10.1097/ogx.0000000000000107

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. / Ledermann, Jonathan; Harter, Philipp; Gourley, Charlie et al.
In: Obstetrical and Gynecological Survey, Vol. 69, No. 10, 2015, p. 594-596.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer

T2 - A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

AU - Ledermann, Jonathan

AU - Harter, Philipp

AU - Gourley, Charlie

AU - Friedlander, Michael

AU - Vergote, Ignace

AU - Rustin, Gordon

AU - Scott, Clare L.

AU - Meier, Werner

AU - Shapira-Frommer, Ronnie

AU - Safra, Tamar

AU - Matei, Daniela

AU - Fielding, Anitra

AU - Spencer, Stuart

AU - Dougherty, Brian

AU - Orr, Maria

AU - Hodgson, Darren

AU - Barrett, J. Carl

AU - Matulonis, Ursula

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84925853373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925853373&partnerID=8YFLogxK

U2 - 10.1097/ogx.0000000000000107

DO - 10.1097/ogx.0000000000000107

M3 - Comment/debate

AN - SCOPUS:84925853373

SN - 0029-7828

VL - 69

SP - 594

EP - 596

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 10

ER -

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this